ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 132275 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 132275; 2) Community: the network communities that were significantly associated with the response to NSC 132275; 3) Molecule: the relationships between components within communities and NSC 132275; 4) MDR: the compounds that were significantly associated with the NSC 132275.

NSC Compound Enrichment Correlation
NSC 718781 Erlotinib hydrochloride 0.029142074732756 -0.3473812
NSC 724783 [1,5-dimethyl-10-(trifluoromethyl)-11,14,15,16-tetraoxatetra cyclo[10.3.1.04,13.08,13]hexadec-9-en-9-yl]-N,N-bis{[1,5-dim ethyl-10-(trifluoromethyl)-11,14,15,16-tetraoxatetracyclo[10 .3.1.04,13.08,13 0.029142074732756 0.2459519
NSC 732205 Null 0.029142074732756 0.24787475
NSC 732936 5,6-Dihydro-6-(3-dimethylamino-1-propyl)-2,3-methylenedioxy- 5,11-dioxo-11H-indeno[1,2-c]isoquinoline 0.029142074732756 0.27115374
NSC 740357 Null 0.029142074732756 -0.035094848
NSC 753598 Null 0.029142074732756 0.22450976
NSC 756375 GW811761X 0.029142074732756 0.1601792
NSC 93819 Depakine 0.029142074732756 0.020412276
NSC 117356 D-Amethopterin 0.0295480456086945 0.63208367
NSC 145668 Cyclocytidine hydrochloride 0.0295480456086947 0.41954305
Total:100  Current:75    [First] [Prev] [Next] [Last]